Cargando…

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

Detalles Bibliográficos
Autores principales: Zharinov, Gennady M., Bogomolov, Oleg A., Chepurnaya, Irina V., Neklasova, Natalia Yu., Anisimov, Vladimir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970077/
https://www.ncbi.nlm.nih.gov/pubmed/36848399
http://dx.doi.org/10.18632/oncotarget.28363
_version_ 1784897846435119104
author Zharinov, Gennady M.
Bogomolov, Oleg A.
Chepurnaya, Irina V.
Neklasova, Natalia Yu.
Anisimov, Vladimir N.
author_facet Zharinov, Gennady M.
Bogomolov, Oleg A.
Chepurnaya, Irina V.
Neklasova, Natalia Yu.
Anisimov, Vladimir N.
author_sort Zharinov, Gennady M.
collection PubMed
description
format Online
Article
Text
id pubmed-9970077
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-99700772023-02-28 Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment Zharinov, Gennady M. Bogomolov, Oleg A. Chepurnaya, Irina V. Neklasova, Natalia Yu. Anisimov, Vladimir N. Oncotarget Addendum Impact Journals LLC 2023-02-25 /pmc/articles/PMC9970077/ /pubmed/36848399 http://dx.doi.org/10.18632/oncotarget.28363 Text en Copyright: © 2023 Zharinov et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Zharinov, Gennady M.
Bogomolov, Oleg A.
Chepurnaya, Irina V.
Neklasova, Natalia Yu.
Anisimov, Vladimir N.
Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title_full Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title_fullStr Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title_full_unstemmed Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title_short Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
title_sort addendum: melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970077/
https://www.ncbi.nlm.nih.gov/pubmed/36848399
http://dx.doi.org/10.18632/oncotarget.28363
work_keys_str_mv AT zharinovgennadym addendummelatoninincreasesoverallsurvivalofprostatecancerpatientswithpoorprognosisaftercombinedhormoneradiationtreatment
AT bogomolovolega addendummelatoninincreasesoverallsurvivalofprostatecancerpatientswithpoorprognosisaftercombinedhormoneradiationtreatment
AT chepurnayairinav addendummelatoninincreasesoverallsurvivalofprostatecancerpatientswithpoorprognosisaftercombinedhormoneradiationtreatment
AT neklasovanataliayu addendummelatoninincreasesoverallsurvivalofprostatecancerpatientswithpoorprognosisaftercombinedhormoneradiationtreatment
AT anisimovvladimirn addendummelatoninincreasesoverallsurvivalofprostatecancerpatientswithpoorprognosisaftercombinedhormoneradiationtreatment